Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016 (2016), Article ID 9737014, 3 pages
http://dx.doi.org/10.1155/2016/9737014
Case Report

Two Cases of Endometrial Cancer in Twin Sisters with Myotonic Dystrophy

Department of Obstetrics & Gynecology, Onze Lieve Vrouwe Gasthuis, 1091 AC Amsterdam, Netherlands

Received 5 May 2016; Accepted 19 July 2016

Academic Editor: Anna Fagotti

Copyright © 2016 Ezra Y. Koh and Paul J. M. van Kesteren. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA—A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Lucenteforte, R. Talamini, M. Montella et al., “Family history of cancer and the risk of endometrial cancer,” European Journal of Cancer Prevention, vol. 18, no. 2, pp. 95–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Terry, J. A. Baron, E. Weiderpass, J. Yuen, P. Lichtenstein, and O. Nyrén, “Lifestyle and endometrial cancer risk: a cohort study from the Swedish twin registry,” International Journal of Cancer, vol. 82, no. 1, pp. 38–42, 1999. View at Google Scholar · View at Scopus
  4. J. S. Kwon, J. L. Scott, C. B. Gilks, M. S. Daniels, C. C. Sun, and K. H. Lu, “Testing women with endometrial cancer to detect lynch syndrome,” Journal of Clinical Oncology, vol. 29, no. 16, pp. 2247–2252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Seebacher, M. Schmid, S. Polterauer et al., “The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study,” BMC Cancer, vol. 9, article 460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Hemminki, J. L. Bermejo, and C. Granström, “Endometrial cancer: population attributable risks from reproductive, familial and socioeconomic factors,” European Journal of Cancer, vol. 41, no. 14, pp. 2155–2159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Beral, D. Bull, G. Reeves et al., “Endometrial cancer and hormone-replacement therapy in the Million Women Study,” The Lancet, vol. 365, no. 9470, pp. 1543–1551, 2005. View at Publisher · View at Google Scholar
  9. D. Thompson and D. F. Easton, “Cancer incidence in BRCA1 mutation carriers,” Journal of the National Cancer Institute, vol. 94, no. 18, pp. 1358–1365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. L. Riegert-Johnson, F. C. Gleeson, M. Roberts et al., “Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients,” Hereditary Cancer in Clinical Practice, vol. 8, no. 1, article 6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Gadalla, M. Lund, R. M. Pfeiffer et al., “Cancer risk among patients with myotonic muscular dystrophy,” Journal of the American Medical Association, vol. 306, no. 22, pp. 2480–2486, 2011. View at Google Scholar · View at Scopus
  12. J. Mathieu, P. Allard, L. Potvin, C. Prévost, and P. Bégin, “A 10-year study of mortality in a cohort of patients with myotonic dystrophy,” Neurology, vol. 52, no. 8, pp. 1658–1662, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Bie and Z. Zhang, “RAB8A a new biomarker for endometrial cancer?” World Journal of Surgical Oncology, vol. 12, article 371, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Attarha, S. Andersson, M. Mints, and S. Souchelnytskyi, “Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers,” British Journal of Cancer, vol. 109, no. 3, pp. 704–713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Roos, J. van Dongen, C. G. Bell et al., “Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs,” Clinical Epigenetics, vol. 8, article 7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Liang, L. W. T. Cheung, J. Li et al., “Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer,” Genome Research, vol. 22, no. 11, pp. 2120–2129, 2012. View at Publisher · View at Google Scholar · View at Scopus